Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$87,942 | -$163,415 | -$135,665 | -$83,988 |
| Dep. & Amort. | $23,629 | $10,829 | $3,681 | $975 |
| Deferred Tax | $0 | $0 | -$6,580 | $595 |
| Stock-Based Comp. | $48,444 | $35,023 | $27,007 | $23,087 |
| Change in WC | $22,591 | -$22,640 | -$21,050 | $16,983 |
| Other Non-Cash | $3,603 | $69,259 | $12,471 | -$90,410 |
| Operating Cash Flow | $10,325 | -$70,944 | -$120,136 | -$132,758 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$993 | -$109 | -$278 | -$19,024 |
| Net Acquisitions | $0 | -$212,762 | -$7,978 | -$19,000 |
| Inv. Purchases | -$89,026 | -$27,329 | -$132,322 | -$198,029 |
| Inv. Sales/Matur. | $19,894 | $153,000 | $140,300 | $157,600 |
| Other Inv. Act. | -$20,000 | -$20,000 | $7,978 | $127,000 |
| Investing Cash Flow | -$90,125 | -$107,200 | $7,700 | $48,547 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $305,304 | $0 | $0 |
| Stock Issued | $17,699 | $216,684 | $107,367 | $6,914 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$185,388 | $1,720 | $66,552 |
| Financing Cash Flow | $17,699 | $336,600 | $109,087 | $73,466 |
| Forex Effect | -$1,297 | -$133 | $12 | -$1 |
| Net Chg. in Cash | -$63,398 | $158,323 | -$3,337 | -$10,746 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $286,326 | $128,003 | $131,340 | $142,086 |
| End Cash | $222,928 | $286,326 | $128,003 | $131,340 |
| Free Cash Flow | $9,332 | -$91,053 | -$120,414 | -$151,782 |